Related Experiment Video
Updated: Jul 27, 2025

08:16
Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model
Published on: February 11, 2019
21.3K
Hyperacute and Fulminant Guillain-Barré Syndrome Requiring Emergent Intubation
James Neumeister1, Derrick Huang1, Shane Dzluneski1
1Emergency Medicine, HCA Florida Ocala Hospital, Ocala, USA.
Cureus
|June 5, 2023
Summary
Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting nerves. Early recognition of its progression and prompt airway management are crucial for effective treatment and preventing respiratory failure.
Area of Science:
- Neurology
- Immunology
- Critical Care Medicine
Background:
- Guillain-Barré syndrome (GBS) is a rare autoimmune disorder.
- It involves acute polyneuropathy, potentially leading to respiratory failure.
- Diagnosis and treatment are challenging due to GBS rarity and varied presentations.
Observation:
- GBS progression varies, with rarer subtypes posing greater risks.
- Neurological deficits can rapidly worsen from onset to nadir.
- High index of suspicion is necessary for timely diagnosis.
Findings:
- Understanding the time course of GBS progression is key.
- Close airway monitoring is essential for patient safety.
- Prompt diagnosis and intervention improve outcomes.
Implications:
- Early recognition and airway management are critical for GBS patients.
- Further research into GBS subtypes and progression patterns is warranted.
- Multidisciplinary care improves GBS patient survival and recovery.
Related Concept Videos
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
24
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
24
Acute Respiratory Failure-III
235
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
235
Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
Depolarizing Blockers: Mechanism of Action
1.7K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.7K
Acute Respiratory Failure-II
291
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
291
Acute Respiratory Failure-IV
181
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
181

